Release date: 30 January 2026
Results
Summary
- Overall antimicrobial dispensing increased from 2022-2024 for inpatients and 2023-2024 for non-inpatients.
- Penicillins and amoxicillin/clavulanate were still the most dispensed, with most top antimicrobials; and doxycycline had notable increase in 2024.
- Antimicrobial dispensing in inpatient services grew across all specialties from 2022-2024, with gradual increase observed in surgery from 2016-2024.
- While broad-spectrum antimicrobials like piperacillin/tazobactam, meropenem, and vancomycin saw reduced inpatient use in 2024, cefepime use continued to rise.
|
Recommendations
- Keep tracking antimicrobial use in HA facilities, exploring the underlying reasons for the sustained increase in dispensing volumes across both inpatient and non-inpatient services to inform stewardship efforts.
- Monitor trends in broad-spectrum antimicrobials, especially the rise in ertapenem and cefepime, to ensure appropriate prescribing and reduce resistance risks.
Acknowledgement
We would like to acknowledge stakeholders from HA including the Information Technology & Health Informatics Division, Quality and Safety Division, Strategy and Planning Division, Chief Pharmacist’s Office, and various Working Groups for provision of input to facilitate compilation of the AMU surveillance findings for year 2024.
Past Reports
Results of the Report 
Access Past Reports